Developer docs
API playgroundTry for free, no card

Search company profiles

MTL Cannabis (formerly Canada House Wellness Group)

Full company profile

uuid0003skb

Namestring
MTL Cannabis (formerly Canada House Wellness Group)
Legal namestring
MTL Cannabis Corp.
Websiteurl
mtlcorp.ca
Company typeenum
Public
Founded yearint
2018
Descriptiontext

MTL Cannabis Corp. is a Canadian licensed producer of premium craft cannabis founded in 2018 by brothers Richard and Michel Clement in Quebec. The company was formed via the 2021 reverse takeover of Canada House Wellness Group and operates three business segments: a Canadian recreational portfolio (flagship MTL Cannabis, value brand LowKey by MTL, and premium Quebec small-batch brand R'Belle), a Canadian medical platform (Abba Medix serving 3,500+ veterans and Canada House Clinics operating 13 clinics across 7 provinces), and an international export business shipping branded products to federally regulated medical markets in Germany and Australia.

The underlying operating asset is four indoor cultivation facilities in Quebec and Ontario producing up to 19,500 kg of high-THC, terpene-rich flower annually, feeding a centralized post-harvest processing and fulfillment hub. Distribution is hybrid: provincial cannabis retailers (notably SQDC in Quebec) for recreational SKUs, the in-house clinic network and Abba Medix platform for medical patients, and export partners for international markets. Reported Q2 FY2026 gross margins before fair-value adjustments were 50% and adjusted EBITDA was $2.2M; full-year FY2025 revenue was $105.2M CAD with $21.7M of EBITDA, up from $83.1M and $13.2M respectively in FY2024.

MTL Cannabis was acquired by Canopy Growth Corporation on March 16, 2026 in a transaction valued at approximately $125M on a fully-diluted equity basis ($179M enterprise value), making it a wholly-owned subsidiary and creating what the acquirer described as Canada's leading medical cannabis business by revenue. Expected run-rate synergies of approximately $10M within 18 months are tied to integrating MTL's medical and cultivation operations into Canopy Growth's distribution footprint.

Short descriptiontext

MTL Cannabis Corp. is a Canadian licensed producer of premium indoor cannabis operating recreational brands (MTL, LowKey, R'Belle), a medical platform (Abba Medix, Canada House Clinics), and exports to Germany and Australia; the company was acquired by Canopy Growth in March 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPickering, Canada
HQ citystring
Pickering
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis cultivation, medical cannabis distribution, recreational cannabis products, cannabis brand portfolio, cannabis international exports
Industry2 codes
1Cannabis Wholesale Distribution (Flower, Extracts, Edibles)
CodeCRAOAIAFPrimaryYes
2Medical Cannabis Dispensaries
CodeCRANAFABPrimaryNo
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Cannabis Cultivation and Distribution
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Recreational Cannabis Sales
TypeOne Time License
Description

Sale of premium craft cannabis products including indoor flower, pre-rolls, and hash through Canadian retail channels including SQDC in Quebec

mtlcorp.ca
2Medical Cannabis Distribution
TypeSubscription Recurring
Description

Distribution of medical cannabis products and services through Abba Medix platform serving veterans and civilians, and Canada House Clinics network

mtlcorp.ca
3International Export
TypeOne Time License
Description

Export of branded cannabis products to federally approved medical cannabis markets including Germany and Australia

mtlcorp.ca
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Supply Chain, Personnel, Infrastructure, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1MTL Cannabis
Description

Flagship brand known for high-THC, terpene-rich indoor flower and precision-rolled pre-rolls. Built for discerning consumers who expect premium quality.

mtlcorp.ca
+4 more records
Core offering1 text field

MTL Cannabis Corp. is a fully integrated licensed cannabis producer that cultivates premium indoor-grown cannabis flower, pre-rolls, and hash at four Canadian facilities in Quebec and Ontario with 19,500 kg annual production capacity. The company distributes branded recreational cannabis through provincial retailers, operates a medical cannabis platform (Abba Medix and 13 Canada House Clinics) serving more than 3,500 veterans, and exports branded products to federally approved medical cannabis markets in Germany and Australia.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 19,500 kg annual indoor cultivation capacity
+3 more records
Product overview1 text field

MTL Cannabis Corp. is a fully integrated licensed cannabis company operating three distinct business segments: Canadian Recreational (featuring flagship brand MTL Cannabis, value brand LowKey by MTL, and premium Quebec brand R'Belle), Canadian Medical Platform (comprising Abba Medix veteran distribution and Canada House Clinics network), and International exports to Germany and Australia. The company operates four Canadian cultivation facilities in Quebec and Ontario with 19,500 kg annual indoor production capacity and a centralized post-harvest processing hub. The company was acquired by Canopy Growth Corporation in March 2026 for approximately $125 million.

Product and service2 records
1MTL Cannabis (Flagship Brand)
CategoryRecreational Cannabis Brand
Description

Flagship brand offering high-THC, terpene-rich indoor flower and precision-rolled pre-rolls for discerning recreational consumers who expect premium quality and consistent genetics.

2LowKey by MTL
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeOthers
Description

Proxy solicitation agent engaged for shareholder meeting to vote on Canopy Growth acquisition. Contact: North American Toll Free: 1-877-452-7184, Outside North America: 416-304-0211

Strategic tierCoreTypeStrategic or Co-development Partner
Description

National clinic network of 13 locations across 7 provinces delivering cannabinoid therapies. Founded by Canadian military veterans, serving veterans and civilians with medical cannabis products and services.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Veteran-focused Canadian medical cannabis distribution platform serving more than 3,500 veterans. Founded by Canadian military veterans, providing best-in-class medical cannabis products and services.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MTL Cannabis (formerly Canada House Wellness Group)

Cannabis Cultivation and Distributionmtlcorp.ca

MTL Cannabis Corp. is a Canadian licensed producer of premium indoor cannabis operating recreational brands (MTL, LowKey, R'Belle), a medical platform (Abba Medix, Canada House Clinics), and exports to Germany and Australia; the company was acquired by Canopy Growth in March 2026.

What MTL Cannabis (formerly Canada House Wellness Group) does

MTL Cannabis Corp. is a Canadian licensed producer of premium craft cannabis founded in 2018 by brothers Richard and Michel Clement in Quebec. The company was formed via the 2021 reverse takeover of Canada House Wellness Group and operates three business segments: a Canadian recreational portfolio (flagship MTL Cannabis, value brand LowKey by MTL, and premium Quebec small-batch brand R'Belle), a Canadian medical platform (Abba Medix serving 3,500+ veterans and Canada House Clinics operating 13 clinics across 7 provinces), and an international export business shipping branded products to federally regulated medical markets in Germany and Australia.

The underlying operating asset is four indoor cultivation facilities in Quebec and Ontario producing up to 19,500 kg of high-THC, terpene-rich flower annually, feeding a centralized post-harvest processing and fulfillment hub. Distribution is hybrid: provincial cannabis retailers (notably SQDC in Quebec) for recreational SKUs, the in-house clinic network and Abba Medix platform for medical patients, and export partners for international markets. Reported Q2 FY2026 gross margins before fair-value adjustments were 50% and adjusted EBITDA was $2.2M; full-year FY2025 revenue was $105.2M CAD with $21.7M of EBITDA, up from $83.1M and $13.2M respectively in FY2024.

MTL Cannabis was acquired by Canopy Growth Corporation on March 16, 2026 in a transaction valued at approximately $125M on a fully-diluted equity basis ($179M enterprise value), making it a wholly-owned subsidiary and creating what the acquirer described as Canada's leading medical cannabis business by revenue. Expected run-rate synergies of approximately $10M within 18 months are tied to integrating MTL's medical and cultivation operations into Canopy Growth's distribution footprint.

MTL Cannabis (formerly Canada House Wellness Group) firmographics

Firmographics
Name
MTL Cannabis (formerly Canada House Wellness Group)
Legal name
MTL Cannabis Corp.
Website
https://mtlcorp.ca
Company type
Public
Founded year
2018
Operating status
Acquired
Headcount range
101–250 employees
Short description
MTL Cannabis Corp. is a Canadian licensed producer of premium indoor cannabis operating recreational brands (MTL, LowKey, R'Belle), a medical platform (Abba Medix, Canada House Clinics), and exports to Germany and Australia; the company was acquired by Canopy Growth in March 2026.
Ownership category
akta.pro rank

MTL Cannabis (formerly Canada House Wellness Group) industry classification

Industry
Product category
Cannabis Cultivation and Distribution
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)
akta.pro secondary industry
Medical Cannabis Dispensaries (CRANAFAB)

Keywords

  • Cannabis cultivation
  • Medical cannabis distribution
  • Recreational cannabis products
  • Cannabis brand portfolio
  • Cannabis international exports

Where MTL Cannabis (formerly Canada House Wellness Group) is headquartered

Location

Headquarters

HQ city
Pickering
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

MTL Cannabis (formerly Canada House Wellness Group) business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. Recreational Cannabis Sales: Sale of premium craft cannabis products including indoor flower, pre-rolls, and hash through Canadian retail channels including SQDC in Quebec
  2. Medical Cannabis Distribution: Distribution of medical cannabis products and services through Abba Medix platform serving veterans and civilians, and Canada House Clinics network
  3. International Export: Export of branded cannabis products to federally approved medical cannabis markets including Germany and Australia

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

MTL Cannabis (formerly Canada House Wellness Group) product offering

Product offering

Core offering

MTL Cannabis Corp. is a fully integrated licensed cannabis producer that cultivates premium indoor-grown cannabis flower, pre-rolls, and hash at four Canadian facilities in Quebec and Ontario with 19,500 kg annual production capacity. The company distributes branded recreational cannabis through provincial retailers, operates a medical cannabis platform (Abba Medix and 13 Canada House Clinics) serving more than 3,500 veterans, and exports branded products to federally approved medical cannabis markets in Germany and Australia.

Product overview

MTL Cannabis Corp. is a fully integrated licensed cannabis company operating three distinct business segments: Canadian Recreational (featuring flagship brand MTL Cannabis, value brand LowKey by MTL, and premium Quebec brand R'Belle), Canadian Medical Platform (comprising Abba Medix veteran distribution and Canada House Clinics network), and International exports to Germany and Australia. The company operates four Canadian cultivation facilities in Quebec and Ontario with 19,500 kg annual indoor production capacity and a centralized post-harvest processing hub. The company was acquired by Canopy Growth Corporation in March 2026 for approximately $125 million.

Differentiator

Problem solved

Functional benefit

Brands

  • MTL Cannabis: Flagship brand known for high-THC, terpene-rich indoor flower and precision-rolled pre-rolls. Built for discerning consumers who expect premium quality.
  • LowKey by MTL
  • R'Belle
  • Abba Medix
  • Canada House Clinics

Products and services

  • MTL Cannabis (Flagship Brand) Flagship brand offering high-THC, terpene-rich indoor flower and precision-rolled pre-rolls for discerning recreational consumers who expect premium quality and consistent genetics.
  • LowKey by MTL

Quantifiable outcome

  • 19,500 kg annual indoor cultivation capacity
  • +3 more outcomes

Companies that use MTL Cannabis (formerly Canada House Wellness Group)

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

MTL Cannabis (formerly Canada House Wellness Group) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

MTL Cannabis (formerly Canada House Wellness Group) partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Laurel Hill Advisory GroupminorOthersProxy solicitation agent engaged for shareholder meeting to vote on Canopy Growth acquisition. Contact: North American Toll Free: 1-877-452-7184, Outside North America: 416-304-0211
  • Canada House ClinicscoreStrategic or Co-development PartnerNational clinic network of 13 locations across 7 provinces delivering cannabinoid therapies. Founded by Canadian military veterans, serving veterans and civilians with medical cannabis products and services.
  • Abba MedixcoreStrategic or Co-development PartnerVeteran-focused Canadian medical cannabis distribution platform serving more than 3,500 veterans. Founded by Canadian military veterans, providing best-in-class medical cannabis products and services.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

MTL Cannabis (formerly Canada House Wellness Group) competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MTL Cannabis (formerly Canada House Wellness Group) social profiles

Digital presence

MTL Cannabis (formerly Canada House Wellness Group) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MTL Cannabis (formerly Canada House Wellness Group) leadership team

Management profile

Number of profiles

Profiles3 records

MTL Cannabis (formerly Canada House Wellness Group) subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

MTL Cannabis (formerly Canada House Wellness Group) funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MTL Cannabis (formerly Canada House Wellness Group) M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MTL Cannabis (formerly Canada House Wellness Group)

What does MTL Cannabis (formerly Canada House Wellness Group) do?

MTL Cannabis Corp. is a fully integrated licensed cannabis producer that cultivates premium indoor-grown cannabis flower, pre-rolls, and hash at four Canadian facilities in Quebec and Ontario with 19,500 kg annual production capacity. The company distributes branded recreational cannabis through provincial retailers, operates a medical cannabis platform (Abba Medix and 13 Canada House Clinics) serving more than 3,500 veterans, and exports branded products to federally approved medical cannabis markets in Germany and Australia.

Is MTL Cannabis (formerly Canada House Wellness Group) a public or private company?

MTL Cannabis (formerly Canada House Wellness Group) is a public company. It is classified as public and is currently acquired.

When was MTL Cannabis (formerly Canada House Wellness Group) founded?

MTL Cannabis (formerly Canada House Wellness Group) was founded in 2018. It employs 101 to 250 people.

Where is MTL Cannabis (formerly Canada House Wellness Group) based?

MTL Cannabis (formerly Canada House Wellness Group) is headquartered in Pickering, Canada, in the North America region.

How does MTL Cannabis (formerly Canada House Wellness Group) make money?

Three revenue lines are on record. Recreational Cannabis Sales are the primary driver. The others are medical Cannabis Distribution and international Export.

Does MTL Cannabis (formerly Canada House Wellness Group) have an API?

No public API is recorded for MTL Cannabis (formerly Canada House Wellness Group).

What industry is MTL Cannabis (formerly Canada House Wellness Group) in?

MTL Cannabis (formerly Canada House Wellness Group)'s product category is Cannabis Cultivation and Distribution. Its primary akta.pro industry code is CRAOAIAF, Cannabis Wholesale Distribution (Flower, Extracts, Edibles), with a secondary code of CRANAFAB, Medical Cannabis Dispensaries. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooCannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell?Canopy Growth Corporation reported first-quarter fiscal 2027 results that beat estimates for both earnings and sales, driven by a 14% year-over-year increase in overall cannabis revenues. The company achieved improved operating performance with adjusted gross margins rising to 31% and narrowed EBITDA losses, supported by the integration of MTL Cannabis.BenzingaCanopy Growth Sees Steady Progress on Profitability Measures - Canopy Growth (NASDAQ:CGC)Canopy Growth reported a first-quarter fiscal 2027 loss of two cents per share, beating the consensus loss of four cents. Sales rose 13% to $58.63 million, with adjusted gross margin improving to 31%. The CFO expects stronger results in the second half as MTL Cannabis integration completes.Financial PostCanopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All BusinessesCanopy Growth Corporation reported its financial results for the first quarter of fiscal year 2027, highlighting a net revenue increase of 13%, attributed to growth across its medical and adult-use cannabis sectors. The company also noted significant improvements in profitability metrics, including a narrower adjusted EBITDA loss, as well as continued integration of MTL Cannabis contributing to product supply and growth opportunities. Canopy Growth aims to leverage its recent successes to enhance its market position in the cannabis industry.Business Wire BlogCanopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By RevenueCanopy Growth has completed its acquisition of MTL Cannabis, creating Canada’s leading medical cannabis business by revenue. The transaction strengthens Canopy Growth's core platform with high-quality flower supply and is expected to generate approximately $10 million in run-rate synergies within 18 months. This move supports the company's strategic objective of achieving positive adjusted EBITDA during fiscal 2027 through expanded operational capabilities.Business Wire BlogCanopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International DemandCanopy Growth Corporation will acquire MTL Cannabis Corp. in a transaction valued at approximately $125 million, aimed at creating Canada’s leading medical cannabis business and addressing growing international demand. This acquisition is expected to generate $10 million in annual cost synergies within 18 months and enhance Canopy Growth's operational footprint in Québec and national distribution capabilities. The transaction is anticipated to close before the end of February 2026, pending shareholder and regulatory approvals.Ottawa Business JournalCanopy Growth signs deal to buy MTL Cannabis in agreement valued at $125MCanopy Growth Corp. has signed a deal to acquire Quebec-based MTL Cannabis Corp. in a transaction valued at approximately $125 million, expected to strengthen Canopy Growth's position in Canada's medical cannabis market. Under the terms, MTL shareholders will receive 0.32 of a common share of Canopy Growth plus 14.4 cents in cash for each MTL share. The deal requires regulatory and MTL shareholder approval and is expected to close before the end of February.Canopy GrowthCanopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International DemandCanopy Growth Corporation announced it will acquire MTL Cannabis Corp. in a transaction valued at approximately $125 million on a fully-diluted equity basis (~$179 million enterprise value), with MTL shareholders receiving 0.32 Canopy Growth shares plus $0.144 cash per share, representing a 45% premium. The deal, expected to close before the end of February 2026 pending shareholder and regulatory approvals, positions the combined entity as Canada's leading medical cannabis provider and is projected to generate approximately $10 million in annualized synergies within 18 months. MTL brings $84 million in trailing twelve-month revenue, two cultivation facilities in Québec, and the #1 national market share in upper mainstream flower, with its core management team expected to join Canopy Growth.New Cannabis VenturesCanopy Growth to Acquire Canadian Cannabis Producer – New Cannabis VenturesCanopy Growth Corporation has entered into a definitive agreement to acquire all outstanding shares of MTL Cannabis Corp. in a transaction valued at approximately $125 million on a fully-diluted equity basis and $179 million on an enterprise value basis. MTL shareholders will receive 0.32 Canopy Growth shares plus $0.144 cash per share, representing a 45% premium to MTL's 20-day volume-weighted average price. The acquisition is expected to generate approximately $10 million in run-rate synergies within 18 months while strengthening Canopy Growth's presence in Quebec and Canada's medical cannabis market.NewswireMTL Cannabis Corp. Reports Second Quarter Results with $25.4 Million of Revenue, Strong Gross Margins, and Strengthened Balance SheetMTL Cannabis Corp. reported Q2 2025 revenue of $25.4 million, a 4% decline from the same quarter last year, with a net loss of $8.3 million compared to net income of $1.2 million in Q2 2024. The company posted positive Adjusted EBITDA of $2.2 million and gross margins of 50%, up 7 percentage points sequentially, while simultaneously completing a $27 million credit facility with a Canadian bank to refinance existing debt and support capital expenditures. The company attributes the year-over-year pressure to ongoing supply chain realignment while positioning for improved profitability.NewswireMTL Cannabis Corp. Announces up to $4 Million Brokered LIFE Offering Led by Centurion One CapitalMTL Cannabis Corp. announced a brokered private placement of units raising up to $4 million, led by Centurion One Capital, with an option to raise an additional $1.75 million. The proceeds will fund capital expenditures and marketing activities, with the offering conducted in Canada and the US, expected to close around August 22, 2025.